I was not expecting it to be cash flow accreditive by now and I...

I was not expecting it to be cash flow accreditive by now and I have been a holder since IPO which was $1. Have bought 3 times since brining down my cost base to around 24c. However their growth has simply just been too slow which means there outgoings are eating into cash reserves. However there Market cap is less than what they have in the bank by some 2 mil and they will claim back 2mil in cash due to R&D rebates.. I am going to give this company 2 more quarters to turn around, otherwise I am bailing at a loss.